Inovio Pharmaceuticals (INO) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company’s earnings picture, ⦠[+5003 chars]Source
